Our study demonstrates that neuroblastoma remains the most frequently encountered tumor type, often with a favorable prognosis due to its potential for spontaneous regression, particularly in low-stage, non-MYCN-amplified cases. The gene discussed is MYCN; the disease is neuroblastoma.